bioRxiv Science⌕ Search

Biology subjects

Briner, A.

Publications and source records attributed to Briner, A..

2 recordsLinked to original sources

Aberrant phase separation is a common killing strategy of positively charged peptides in biology and human disease

Positively charged repeat peptides are emerging as key players in neurodegenerative diseases. These peptides can perturb diverse cellular pathways but a unifying framework for how such promiscuous toxicity arises has remained elusive. We used mass-spectrometry-based proteomics to define the protein targets of these neurotoxic peptides and found that they all share similar sequence features that drive their aberrant condensation with these positively charged peptides. We trained a machine learning algorithm to detect such sequence features and unexpectedly discovered that this mode of toxicity is not limited to human repeat expansion disorders but has evolved countless times across the tree of life in the form of cationic antimicrobial and venom peptides. We demonstrate that an excess in positive charge is necessary and sufficient for this killer activity, which we name polycation poisoning. These findings reveal an ancient and conserved mechanism and inform ways to leverage its design rules for new generations of bioactive peptides.

cell biology↗

Genome-wide CRISPRi screening reveals regulators of Alzheimee's tau pathology shared between exosomal and vesicle-free tau seeds.

Aggregation of the microtubule-associated protein tau is a defining feature of Alzheimers disease and other tauopathies. Tau pathology is believed to be driven by both free tau aggregates and tau carried within exosomes, which propagate trans-synaptically and induce tau pathology in recipient neurons by a corrupting process of seeding. Here, we performed a genome-wide CRISPRi screen in tau biosensor cells and identified cellular regulators shared by both mechanisms of tau seeding. The top validated regulators are ANKLE2, BANF1, NUSAP1, EIF1AD, and VPS18, which work as factors that restrict tau aggregation initiated by both exosomal and vesicle-free tau seeds. Interestingly, ANKLE2 and BANF1 more robustly affected exosomal tau seeding than free aggregates. Lastly, validation studies revealed that several of the identified protein hits are downregulated in the brains of Alzheimers patients, suggesting that their decreased activity may be required for the emergence or progression of tau pathology in the human brain.

neuroscience↗